Technologies Available for Licensing
PLASMODIUM LIVER STAGE ANTIGENS
The invention provides isolated liver stage Plasmodium polypeptides comprising an amino acid sequence selected from the group consisting of SEQ ID NOs: 1-48 and immunogenic derivatives thereof. The invention also provides isolated nucleic acid molecules encoding the liver stage Plasmodium polypeptides of the invention, compositions comprising one or more liver stage Plasmodium polypeptides of the invention, methods for inducing an immune response against the liver stage Plasmodium polypeptides, and methods for treating and diagnosing liver stage malaria.
Docket:WRAIR 04-09A
Publication/Issued No.:7,722,889
Publication/Issue Date:2010-05-25
Categories: Vaccine
More Detail:Visit USPTO.GOV
Lab:WRAIR
Inventor(s):DUFFY, P.; KRZYCH, U.; HEPPNER, D. JR.; MALKOV, V.; WENDLER, J.; BACIK, I.